Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: Evidence for involvement at the hematopoietic stem cell level

Blood

Volumn 96, Issue 6, 2000, Pages 2012-2021

  Nilsson, L ^a   Astrand Grundstrom, I ^a   Arvidsson, I ^a   Jacobsson, B ^a   Hellstrom Lindberg, E ^a   Hast, R ^a   Jacobsen, S E W ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; B LYMPHOBLAST; CHROMOSOME 5Q; CHROMOSOME DELETION 5; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034665776     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.6.2012     Document Type: Article

References (67)

1. Myelodysplastic syndromes
2. Myelodysplasia
3. Myelodysplastic syndrom
4. Chromosome abnormalities in the myelodysplastic syndromes
5. Refined chromosome study helps define prognostic sub-groups in most patients with primary myelodys-plastic syndrome and acute myelogenous leukaemia
6. Chromosome abnormalities in myelodys-plastic syndromes
7. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome: Prognostic significance of morphology and chromosome findings
8. Cytogenetic findings in 179 patients with myelodysplastic syndromes
9. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes
10. Cytogenetics and neoplasia, new techniques to detect chromosomal abnormalities
11. Clonal analysis using X-linked DNA polymorphisms
12. Clonal analysis of myelodysplastic syndromes: Evidence of multipotent stem cell origin
13. Lineage specificity in haematological neoplasms
14. Acute nonlymphocytic leukemia: Heterogeneity of stem cell origin
15. Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982)
16. Pathobiology of acute myeloid leukemia
17. Clonality in myelodysplastic syndromes
18. Evidence for a multistep pathogenesis of a myelodysplastic syndrome
19. Cytogenetic evidence for involvement of B lymphocytes in acquired idiopathic sideroblastic anemias
20. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms
21. Clonal lymphocytes are detectable in only some cases of MDS
22. Deletion of chromosome 20q in myelodysplasia can occur in a multi-potent precursor of both myeloid cells and B cells
23. On the 5q- deletion: Clinical and cytogenetic observations in ten patients and review of the literature
24. Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses
25. Clonal analysis of myelodysplastic syndrome: Monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization
26. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: Analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phospho-glycerate kinase gene
27. Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization
28. Myeloid but not lymphoid cells carry the 5q deletion: Polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions
29. In situ hybridization on May-Grunwald Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic abnormalities
30. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH)
31. Combined immunophenotyping and in situ hybridization (FICTION): A rapid method to study cell lineage involvement in myelodysplastic syndromes
32. Study of clonality in myelodysplastic syndromes: Detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization
33. Cytogenetic clonality analysis: Typical patterns in myelodysplastic syndrome and acute myeloid leukaemia
34. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology
35. Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells
36. The biology of chronic myeloid leukemia
37. Distinct haematological disorder with deletion of long arm of no. 5 chromosome
38. The 5q-anomaly
39. The 5q-syndrome
40. 5q-, twenty-five years later: A synopsis
41. International scoring system for evaluating prognosis in myelodysplastic syndromes
42. Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following M.D.S.: Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation
43. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells
44. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population
45. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
46. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
47. Proposals for the classification of the myelodysplastic syndromes
48. Distinct requirements for optimal growth and in vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells
49. Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears
50. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multi-lineage potential at the single-cell level: Key role of thrombopoietin
51. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
52. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice
53. Differentiation and proliferation of hematopoietic stem cells
54. Myelopoiesis
55. Normal and leukemic human stem cells assayed in SCID mice
56. The human/sheep xenograft model: A large animal model of human hematopoiesis
57. Self-renewal, differentiation or death: Regulation and manipulation of hematopoietic stem cell fate
58. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: Distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha
59. Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation
60. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia
61. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations
62. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodys-plastic syndromes
63. Isolation of a candidate human hematopoietic stem-cell population
64. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset
65. Identification of clonogenic common lymphoid progenitors in mouse bone marrow
66. Lymphocyte survival in men treated with x-rays for ankylosing spondylitis
67. Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization